DEF 14C

OXIS SCHEDULE 14C

Company: GT Biopharma, Inc.
Filed: January 20, 2011
Period of Report: January 20, 2011
Accession Number: 0000109657-11-000004

View Document ↗ View on SEC.gov ↗